140 related articles for article (PubMed ID: 4136451)
1. [Susceptibility of drug-resistant tubercle bacilli isolated from pulmonary tuberculosis in patients to paromomycin (Aminosidine) (author's transl)].
Endo K
Jpn J Antibiot; 1974 Apr; 27(2):141-3. PubMed ID: 4136451
[No Abstract] [Full Text] [Related]
2. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
[No Abstract] [Full Text] [Related]
3. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
Tsukamura M; Mizuno S; Murata H; Oshima T
Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
[No Abstract] [Full Text] [Related]
4. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
Tsukamura M
Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
[No Abstract] [Full Text] [Related]
5. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
[No Abstract] [Full Text] [Related]
6. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
Fukuhara Y
Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
[No Abstract] [Full Text] [Related]
7. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
[No Abstract] [Full Text] [Related]
8. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
Tsukamura M; Mizuno S
J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
[TBL] [Abstract][Full Text] [Related]
9. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
Endo K
Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
[No Abstract] [Full Text] [Related]
10. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
McClatchy JK; Kanes W; Davidson PT; Moulding TS
Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
[TBL] [Abstract][Full Text] [Related]
11. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
Endo K
Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
[No Abstract] [Full Text] [Related]
12. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
Tomoda T; Minami Y; Maekawa Y; Oi Y
Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
[No Abstract] [Full Text] [Related]
13. [Isolation of tubercle bacilli resistant to kanamycin or viomycine from tuberculous patients].
Endo K; Takahashi M; Hashimoto H; Mitsuhashi S
J Antibiot B; 1967 Aug; 20(4):251-3. PubMed ID: 4295238
[No Abstract] [Full Text] [Related]
14. Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis.
Tsukamura M
Microbiol Immunol; 1980; 24(1):11-9. PubMed ID: 6153747
[No Abstract] [Full Text] [Related]
15. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
Shimizu T
Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
[No Abstract] [Full Text] [Related]
16. Studies on lividomycin. I. In vitro antibacterial activities of LVDM against clinical isolates of Mycobacterium tuberculosis.
Shimizu T
Jpn J Antibiot; 1974 Dec; 27(6):766-74. PubMed ID: 4142798
[No Abstract] [Full Text] [Related]
17. [Isolation of kanamycin or viomycin-resistant M. tuberculosis from tuberculous patients].
Endo K; Takahashi M; Hashimoto H; Mitsuhashi S
J Antibiot B; 1967 Feb; 20(1):1-5. PubMed ID: 4292905
[No Abstract] [Full Text] [Related]
18. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
Tsukamura M
Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
[No Abstract] [Full Text] [Related]
19. The antimycobacterial activity of capreomycin.
Lucchesi M
Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
[No Abstract] [Full Text] [Related]
20. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
Tsukamura M; Toyama H; Mizuno S; Tsukamura S
Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
